Cart
sales@molnova.com
SPOP-IN-6lc
CAS No. 2136270-56-7
SPOP-IN-6lc( —— )
Catalog No. M36313 CAS No. 2136270-56-7
SPOP-IN-6lc is a potent SPOP inhibitor with multiple roles in cancer, oncostatic in a variety of tumors, but functions as an oncogene in renal cancer.SPOP-IN-6lc can be used to study cell signaling and apoptosis.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 233 | In Stock |
|
| 5MG | 366 | In Stock |
|
| 10MG | 587 | In Stock |
|
| 25MG | 1067 | In Stock |
|
| 50MG | 1435 | In Stock |
|
| 100MG | 1881 | In Stock |
|
| 500MG | 3807 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSPOP-IN-6lc
-
NoteResearch use only, not for human use.
-
Brief DescriptionSPOP-IN-6lc is a potent SPOP inhibitor with multiple roles in cancer, oncostatic in a variety of tumors, but functions as an oncogene in renal cancer.SPOP-IN-6lc can be used to study cell signaling and apoptosis.
-
DescriptionSPOP-IN-1 is a selective SPOP E3 ubiquitin ligase inhibitor. SPOP-IN-1 leads to the accumulation of tumor suppressors PTEN and DUSP7 and decreased levels of phosphorylated AKT and ERK in clear-cell renal cell carcinoma.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetApoptosis
-
RecptorApoptosis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2136270-56-7
-
Formula Weight505.64
-
Molecular FormulaC26H31N7O2S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(CC1=CC=CS1)N2C3=C(C(=O)N4C(=N3)C(C)=CC=C4)C=C(C(NCCN5CCN(C)CC5)=O)C2=N
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Dong Z, et al. Structure-Activity Relationship of SPOP Inhibitors against Kidney Cancer. J Med Chem. 2020 May 14;63(9):4849-4866. ?
molnova catalog
related products
-
BTM-3528
BTM-3528 is an activator of the mitochondrial protease OMA1 with anticancer activity.BTM-3528 activates the ISR via the mitochondrial protease OMA1, inducing OMA1-dependent cleavage of DELE1 and OPA1 and mitochondrial fragmentation.
-
Glycerol trioleate
Glyceryl Trioleate has been investigated for the treatment of Adrenoleukodystrophy.
-
RSH-7
RSH-7 is a potent dual inhibitor of BTK and FLT3, with IC50s of 47 and 12 nM, respectively.RSH-7 has antiproliferative and antitumor activities, inducing apoptosis and inhibiting BTK and FLT3 signaling.
